Funding Received
$17.7 Million in 3 Rounds from 4 Investors
Most Recent Funding
$5.7 Million Private Equity on February 21, 2013
Headquarters:
Yavneh
Description:
Avraham Pharmaceuticals, a pharmaceutical company, develops novel products for the treatment and prevention of neurodegenerative disorders.
Categories:
Biotechnology
Website:
http://www.avphar.com

Detailed Description

Update

Avraham Pharmaceuticals (“Avraham”) is a privately held, emerging pharmaceutical company developing novel products for treatment and/or prevention of neurodegenerative disorders. Founded in 2010, Avraham has raised $9 million to conduct a European Phase II proof-of-concept efficacy trial in patients with Alzheimer's disease, supporting the development of its lead product candidate, ladostigil.

Current Team (1)

Update

Investors (4)

Update

Offices/Locations (1)

Update
  • Office

    42 Hayarkon st.

    Northern Industrial Zone

    Yavneh, 81227

    ISR